Tuesday, May 29, 2018

Top 10 Growth Stocks To Buy Right Now

tags:TBI,MED,JWN,BWLD,ISRG,

Square Cash, the mobile payment app developed by Square, is growing faster than PayPal's Venmo, according to Nomura Instinet.

Since early 2016, Square Cash app downloads have averaged 128 percent year-over-year growth each month versus Venmo's 74 percent average monthly year-over-year growth, according to Nomura analysis.

With roughly 28 million cumulative downloads, the number of Square Cash downloads is just 1 million below Venmo's levels, according to analyst Dan Dolev.

"Historically, Venmo saw more downloads versus Square, but the gap appears to have peaked in July 2017," Dolev wrote to clients Wednesday, reiterating his buy rating on the stock.

The app appears to be getting an added boost because it allows transactions in bitcoin, the analyst noted.

Top 10 Growth Stocks To Buy Right Now: TrueBlue Inc.(TBI)

Advisors' Opinion:
  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Stephan Byrd]

    American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.

Top 10 Growth Stocks To Buy Right Now: MEDIFAST INC(MED)

Advisors' Opinion:
  • [By Max Byerly]

    McCormick & Company, Incorporated (NYSE: MKC) and Medifast (NYSE:MED) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings. Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share. California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings. Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results. Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance. Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter. Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results. Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results. B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings. HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Joseph Griffin]

    MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

  • [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings. Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744. Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results. California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings. Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results. Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance. Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46. Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results. Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter. Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36. Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result

Top 10 Growth Stocks To Buy Right Now: Nordstrom Inc.(JWN)

Advisors' Opinion:
  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Nordstrom, Inc. (NYSE: JWN) which traded down about 2% at $51.92. The stock��s 52-week range is $37.79 to $54.00. Volume was 2.3 million compared to the daily average volume of 2.0 million.

  • [By Stephan Byrd]

    Nordstrom, Inc. (NYSE:JWN) insider Ken Worzel sold 13,703 shares of the company’s stock in a transaction on Wednesday, April 11th. The shares were sold at an average price of $48.97, for a total value of $671,035.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Adam Levine-Weinberg]

    Nordstrom (NYSE:JWN) returned to earnings growth last quarter, as the reduced corporate tax rate helped the upscale retailer post a double-digit increase in earnings per share. Investors still dumped Nordstrom stock in after-hours trading on Thursday, punishing the company for weak comparable-store sales growth.

  • [By Jeremy Bowman]

    Shares of�Nordstrom Inc.�(NYSE:JWN) were heading lower today after the department store chain turned in a disappointing first-quarter earnings report with comparable sales coming in lower than expected. As a result, the stock was down 9.2% as of 11:17 a.m. EDT.�

  • [By Zacks]

    We have Macy's (NYSE: M), Nordstrom (NYSE: JWN), Wal-Mart (NYSE: WMT), and Home Depot (NYSE: HD) reporting this week.  While the earnings reports will give us the historical data, this week's retail sales data will give us some insight on how well the sector is doing overall in the beginning of Q2.

  • [By Garrett Baldwin]

    Crude oil prices continue to remain in focus after Brent crude hit $80.00 per barrel. The benchmark crude touched $80.00, as markets are concerned about the impact renewed Iranian sanctions will have on global supply. French oil giant Total announced Wednesday that it was abandoning a gas project in Iran after failing to obtain a waiver from the Trump administration to do business in Iran. The sanctions are expected to decline global output at a time that OPEC is already working diligently to push oil prices higher by containing excessive global production. Four Stocks to Watch Today: JCP, BABA, F, KR Shares of JCPenney (NYSE: JCP) are ticking higher after its earnings report before the bell. Yesterday, retail companies were stunned by the 11% jump for its rival Macy's Inc. (NYSE: M) stock thanks to a strong first-quarter report. Alibaba Group Holding Ltd.�(NYSE: BABA) is generating a lot of buzz as investors monitor trade relations between the United States and China. BABA stock had slumped by 18% thanks to trade restrictions on Chinese companies. Ford Motor Co.�(NYSE: F) announced it will restart production of its popular F-150 pickup truck at its Dearborn, Mich., facility. The company recently suspended operations after a fire damaged supplies needed for manufacturing. The F-150 is the most popular consumer vehicle in the United States. In an effort to beat back the growth of Wal-Mart and Amazon, grocery giant Kroger Co.�(NYSE: KR) announced a deal to purchase a 5% stake in British online supermarket Ocado. The deal will allow Kroger to utilize the UK firm's warehouse automation technology in the United States and improve its supply chain costs. Look for additional earnings reports from Applied Materials Inc.�(Nasdaq: AMAT), Nordstrom Inc. (NYSE: JWN), The Children's Place Inc.�(Nasdaq: PLCE), Teekay Corp.�(NYSE: TK), and Quantum Corp.�(NYSE: QTM).

    Follow�Money Morning��on��Facebook,�Twitter, and�LinkedIn.

Top 10 Growth Stocks To Buy Right Now: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:
  • [By Steve Symington]

    That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment�tripling in value�before falling back while�small cap upscale gentlemen's clubs and restaurant owner�RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap�Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby��s Restaurant Group:

Top 10 Growth Stocks To Buy Right Now: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:
  • [By Motley Fool Staff]

    Right now, it's time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise�(NASDAQ:AAXN), Grupo Aeroportuario del Pacific�(NYSE:PAC), ResMed�(NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation�(NYSE:LYV).

  • [By Chris Hill]

    But there was more upbeat news elsewhere, with No. 3 airline United Continental�(NYSE:UAL) beating on earnings and freight rail titan CSX�(NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical�(NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it's a win-win that Amazon.com�(NASDAQ:AMZN) and Best Buy�(NYSE:BBY) are joining forces to sell smart TVs.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuitive Surgical, Inc. (NASDAQ: ISRG) which rose over 6% to $423.76. The stock��s 52-week range is $217.19 to $426.98. Volume was 1.7 million compared to its average volume of nearly 1 million.

  • [By Garrett Baldwin]

    Earnings season is now in full swing, with today's key reports from�International Business Machines Corp. (NYSE: IBM), Johnson & Johnson (NYSE: JNJ), and Intuitive Surgical Inc.�(Nasdaq: ISRG). Thanks to tax cuts, expectations are high. Analysts expect profit growth to top 18%, which would be the biggest jump in seven years. But there are a few bearish trends that are still lurking in the market. And if you're serious about making money, you need to know how to harness them and target individual stocks for life-changing gains.�Money Morning�Quantitative Specialist Chris Johnson explains.

  • [By Brian Feroldi]

    TransEnterix (NYSEMKT:TRXC) recently surprised investors on the upside when it reported its first-quarter results. The company's�Senhance�surgical system is off to a fast start right out of the gate, and it has attracted a lot of positive attention from the medical community. This just goes to show how much demand is out there for an�alternative to Intuitive Surgical's (NASDAQ: ISRG)�dominant da Vinci platform.�

  • [By Motley Fool Staff]

    In the healthcare world, one of those has to be the impressive quarterly report from Intuitive Surgical�(NASDAQ:ISRG). The company increased its revenue by 25%, and accelerated its sales of the da Vinci robotic surgical systems that made it famous. But it's not just the expensive hardware that is allowing it to prosper -- it's that every machine needs a steady supply of the disposable instruments and accessories used during its procedures. The Fools consider the recent numbers, the outlook, and the investment thesis for Intuitive Surgical stock. But in the, say, anti-healthcare space, cigarette slinger�Philip Morris International�(NYSE:PM) took a big hit as demand slackened in major foreign markets. Sales of its e-cig devices are also not growing the way management had hoped.

Monday, May 28, 2018

$6.01 Billion in Sales Expected for Marriott International Inc (MAR) This Quarter

Analysts forecast that Marriott International Inc (NASDAQ:MAR) will announce sales of $6.01 billion for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Marriott International’s earnings, with the highest sales estimate coming in at $6.14 billion and the lowest estimate coming in at $5.94 billion. Marriott International posted sales of $5.80 billion during the same quarter last year, which would indicate a positive year over year growth rate of 3.6%. The business is expected to announce its next quarterly earnings results on Monday, August 6th.

On average, analysts expect that Marriott International will report full-year sales of $22.53 billion for the current financial year, with estimates ranging from $21.20 billion to $23.24 billion. For the next year, analysts anticipate that the firm will report sales of $23.64 billion per share, with estimates ranging from $22.82 billion to $24.68 billion. Zacks’ sales averages are a mean average based on a survey of analysts that cover Marriott International.

Get Marriott International alerts:

Marriott International (NASDAQ:MAR) last released its earnings results on Tuesday, May 8th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.12. The firm had revenue of $5.01 billion during the quarter, compared to the consensus estimate of $5.78 billion. Marriott International had a return on equity of 41.82% and a net margin of 6.29%. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.01 earnings per share.

A number of equities research analysts have weighed in on the company. Zacks Investment Research downgraded Marriott International from a “buy” rating to a “hold” rating in a research report on Tuesday. Evercore ISI upgraded Marriott International from an “in-line” rating to an “outperform” rating and upped their target price for the stock from $146.00 to $155.00 in a research report on Thursday, May 17th. Deutsche Bank restated a “hold” rating and issued a $141.00 target price on shares of Marriott International in a research report on Thursday, May 10th. Robert W. Baird reiterated a “hold” rating and set a $138.00 price objective on shares of Marriott International in a research report on Thursday, April 19th. Finally, ValuEngine upgraded Marriott International from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Eight investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $133.15.

In other Marriott International news, Director Mary K. Bush sold 2,184 shares of the business’s stock in a transaction on Tuesday, May 15th. The shares were sold at an average price of $138.84, for a total transaction of $303,226.56. Following the sale, the director now directly owns 275 shares of the company’s stock, valued at approximately $38,181. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Stephen Blake Marriott sold 1,000 shares of the business’s stock in a transaction on Friday, March 9th. The shares were sold at an average price of $143.83, for a total transaction of $143,830.00. Following the sale, the insider now directly owns 144,601 shares in the company, valued at $20,797,961.83. The disclosure for this sale can be found here. Insiders have sold a total of 17,606 shares of company stock valued at $2,477,674 in the last quarter. Insiders own 12.99% of the company’s stock.

A number of large investors have recently made changes to their positions in MAR. Suntrust Banks Inc. increased its stake in shares of Marriott International by 3.3% in the first quarter. Suntrust Banks Inc. now owns 59,612 shares of the company’s stock worth $8,105,000 after acquiring an additional 1,897 shares during the last quarter. Amalgamated Bank increased its stake in shares of Marriott International by 10.7% in the first quarter. Amalgamated Bank now owns 44,563 shares of the company’s stock worth $6,060,000 after acquiring an additional 4,323 shares during the last quarter. Summit Trail Advisors LLC increased its stake in shares of Marriott International by 46.4% in the first quarter. Summit Trail Advisors LLC now owns 3,937 shares of the company’s stock worth $262,000 after acquiring an additional 1,248 shares during the last quarter. CIBC World Markets Inc. increased its stake in shares of Marriott International by 75.3% in the first quarter. CIBC World Markets Inc. now owns 39,078 shares of the company’s stock worth $5,314,000 after acquiring an additional 16,785 shares during the last quarter. Finally, Moors & Cabot Inc. acquired a new position in shares of Marriott International in the first quarter worth $256,000. 63.95% of the stock is currently owned by institutional investors.

MAR traded up $0.10 during trading on Monday, reaching $137.97. The stock had a trading volume of 1,396,668 shares, compared to its average volume of 1,884,553. The company has a market capitalization of $48.72 billion, a price-to-earnings ratio of 31.64, a price-to-earnings-growth ratio of 2.17 and a beta of 1.36. The company has a debt-to-equity ratio of 2.20, a current ratio of 0.49 and a quick ratio of 0.49. Marriott International has a 1-year low of $96.90 and a 1-year high of $149.21.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, May 18th will be given a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Thursday, May 17th. This is an increase from Marriott International’s previous quarterly dividend of $0.33. Marriott International’s dividend payout ratio is 37.61%.

Marriott International Company Profile

Marriott International, Inc operates, franchises, and licenses hotel, residential, and timeshare properties worldwide. The company operates through three segments: North American Full-Service, North American Limited-Service, and Asia Pacific. It operates its properties under the JW Marriott, The Ritz-Carlton, W Hotels, The Luxury Collection, St.

Get a free copy of the Zacks research report on Marriott International (MAR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Marriott International (NASDAQ:MAR)

Sunday, May 27, 2018

Top 5 Low Price Stocks To Own For 2018

tags:ADSK,HASI,HGSH,AHL,SWK,

I recently stumbled on a snippet of DA Davidson��s research on Roku (ROKU). The research analyst had a price target of $30 before bumping it to $32 after Q1 earnings. The bearish price target is in line with many other bears (i.e. Morgan Stanely, Citi, etc.); however, the method through which the analyst arrived at the $30 price target looks very wrong.

Instead of using simple near-term multiples to justify a low price target (as is the case with the Morgan Stanley analyst), the analyst used a discounted cash flow model. It is the right approach as a DCF model allows an investor to appreciate a company��s long-term potential. However, I can��t seem to reconcile his assumptions with a probable outcome in the real world.

Source: benzinga.com

Top 5 Low Price Stocks To Own For 2018: Autodesk, Inc.(ADSK)

Advisors' Opinion:
  • [By Stephan Byrd]

    Massachusetts Financial Services Co. MA lessened its stake in Autodesk (NASDAQ:ADSK) by 2.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 523,354 shares of the software company’s stock after selling 15,426 shares during the period. Massachusetts Financial Services Co. MA owned 0.24% of Autodesk worth $65,722,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Daniel Sparks]

    As earnings season starts to taper off, there are some stragglers in tech still reporting earnings. Design software company Autodesk (NASDAQ:ADSK) was one notable company to report quarterly results last week.

  • [By Chris Lange]

    Autodesk Inc. (NASDAQ: ADSK) is poised to post its most recent quarterly results Thursday. The consensus forecast is $0.03 in EPS and $557.37 million in revenue. Shares closed at $138.85 apiece. The consensus price target is $148.25, and the 52-week range is $99.22 to $141.26.

  • [By Joseph Griffin]

    Burney Co. decreased its stake in shares of Autodesk (NASDAQ:ADSK) by 3.1% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,772 shares of the software company’s stock after selling 630 shares during the quarter. Burney Co.’s holdings in Autodesk were worth $2,483,000 at the end of the most recent quarter.

Top 5 Low Price Stocks To Own For 2018: Hannon Armstrong Sustainable Infrastructure Capital, Inc.(HASI)

Advisors' Opinion:
  • [By Lee Jackson]

    This is another solid value at current levels. Hannon Armstrong Sustainable Infrastructure Capital Inc. (NYSE: HASI) is a specialty finance company that directly originates debt and equity investments for sustainable infrastructure projects. The company��s projects focus on products that increase energy efficiency, offer cleaner energy sources and efficiently use natural resources.

Top 5 Low Price Stocks To Own For 2018: China HGS Real Estate, Inc.(HGSH)

Advisors' Opinion:
  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5) My Size Inc. (Nasdaq: MYSZ) $1.66 152.28% Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52% DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02% CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71% China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58% Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12% Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01% Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5% Cenveo Inc. (Nasdaq: CVO) $1.20 31.82% EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%


    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it's completely free…

Top 5 Low Price Stocks To Own For 2018: Aspen Insurance Holdings Limited(AHL)

Advisors' Opinion:
  • [By Ethan Ryder]

    The Travelers Companies (NYSE: TRV) and Aspen Insurance (NYSE:AHL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aspen Insurance (AHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Own For 2018: Stanley Black & Decker Inc.(SWK)

Advisors' Opinion:
  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Stanley Black & Decker, Inc. (NYSE: SWK) which traded down about 7% at $144.02. The stock��s 52-week range is $133.25 to $176.62. Volume was 3.3 million compared to the daily average volume of 1.3 million.

  • [By Logan Wallace]

    In other news, SVP Joseph R. Voelker sold 3,284 shares of Stanley Black & Decker stock in a transaction on Monday, March 5th. The shares were sold at an average price of $151.44, for a total transaction of $497,328.96. Following the transaction, the senior vice president now directly owns 20,367 shares of the company’s stock, valued at $3,084,378.48. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.69% of the company’s stock.

    COPYRIGHT VIOLATION WARNING: “Stanley Black & Decker (SWK) Issues FY18 Earnings Guidance” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3373620/stanley-black-decker-swk-issues-fy18-earnings-guidance.html.

    Stanley Black & Decker Company Profile

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here's why they did so poorly.

  • [By Joseph Griffin]

    Toronto Dominion Bank increased its position in shares of Stanley Black & Decker, Inc. (NYSE:SWK) by 161.4% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 172,665 shares of the industrial products company’s stock after purchasing an additional 106,620 shares during the period. Toronto Dominion Bank’s holdings in Stanley Black & Decker were worth $26,450,000 as of its most recent SEC filing.

  • [By Adam Levine-Weinberg]

    In early 2017, Sears Holdings (NASDAQ:SHLD) sold the rights to its storied Craftsman tool brand to Stanley Black & Decker (NYSE:SWK). Stanley Black & Decker agreed to pay $525 million upfront -- plus supplemental payments with an estimated present value of at least $375 million -- for the right to manufacture and sell Craftsman-branded products outside of Sears Holdings-affiliated channels.

Saturday, May 26, 2018

Top Value Stocks To Watch For 2019

tags:NPI,REGI,SORL,YGE,PTNR,SBLK,

Recently the market was disappointed by Unilever's (NYSE:UL) earnings. On the 26th of January, the stock plummeted by around 5% to $40.7 per share. Therefore, we decided to see whether Unilever offers good value at these prices and, in doing so, we will compare Unilever with other two giants like Procter and Gamble (NYSE:PG) and Nestl茅 (OTCPK:NSRGY).

More or less, all three companies supply food, home and personal care products. Most of their brands are well known. Unilever is home to Persil, Dove, Knorr, Domestos, Hellmann's, Lipton, Wall's, PG Tips, Ben & Jerry's, Marmite, Magnum and Lynx.

Nestl茅 produces its famous chocolates, Kit & Kat, Nesquik, Nescafe, various water brands such as San Pellegrino, Perrier, Vittel and Nestea. It also owns ice creams such as Movenpick and pet products (Purina, Felix, Friskies). In addition, the company controls a minority stake in L'Oreal.

P&G owns many wonderful brands such as Ambi Pur, Ariel, Braun, Febreze, Gillette, Head and Shoulders, Olay, Oral-B, Pampers, Pantene Pro-V, Tampax, Tide, Vicks.

Top Value Stocks To Watch For 2019: Nuveen Premium Income Municipal Fund, Inc.(NPI)

Advisors' Opinion:
  • [By Logan Wallace]

    Northland Power (TSE:NPI) is set to release its earnings data after the market closes on Wednesday, May 9th. Analysts expect Northland Power to post earnings of C$0.45 per share for the quarter.

Top Value Stocks To Watch For 2019: Renewable Energy Group, Inc.(REGI)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday. Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday. NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors. Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15. NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading. Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday. Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday. Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday. Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading. TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday. CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading. Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading. International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading. Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday. Finisar
  • [By Lisa Levin] Gainers Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000. Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting. Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063. Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65. Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12. ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743. Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp. Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy. Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875. Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy. Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15. Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23. NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Lisa Levin]

    Monday afternoon, the energy shares rose 0.73 percent. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ: REGI), up 11 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) up 7 percent.

  • [By Max Byerly]

    Renewable Energy Group Inc (NASDAQ:REGI) was the target of some unusual options trading activity on Thursday. Stock traders acquired 728 call options on the company. This is an increase of approximately 522% compared to the average daily volume of 117 call options.

  • [By Lisa Levin]

    Monday morning, the energy shares rose 0.86 percent. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ: REGI), up 10 percent, and Comstock Resources, Inc. (NYSE: CRK) up 5 percent.

  • [By Lisa Levin]

    Tuesday morning, the energy shares rose 0.73 percent. Meanwhile, top gainers in the sector included Renewable Energy Group, Inc. (NASDAQ: REGI), up 11 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) up 7 percent.

Top Value Stocks To Watch For 2019: SORL Auto Parts Inc.(SORL)

Advisors' Opinion:
  • [By Lisa Levin]

    SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.

    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is projected to report quarterly loss at $0.39 per share.

  • [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin]

    Shares of SORL Auto Parts, Inc. (NASDAQ: SORL) got a boost, shooting up 13 percent to $5.90 after reporting upbeat Q1 results.

    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares were also up, gaining 24 percent to $27.3947 following Q3 results.

  • [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss. Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results. Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88. Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results. SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results. Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat. Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results. LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results. ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results. Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. MYnd

Top Value Stocks To Watch For 2019: Yingli Green Energy Holding Company Limited(YGE)

Advisors' Opinion:
  • [By Paul Ausick]

    Yingli Green Energy Holding Co. Ltd. (NYSE: YGE) slipped about 1.2% to post a new 52-week low of $1.68 Friday after closing at $1.70 on Thursday. The 52-week high is $3.35. Volume of about 5.9 million was more than 15 times the daily average of around 88,000. The company had no specific news.

Top Value Stocks To Watch For 2019: Partner Communications Company Ltd.(PTNR)

Advisors' Opinion:
  • [By Joseph Griffin]

    Partner Communications (NASDAQ: PTNR) and Hutchison Telecommunications Hong Kong (OTCMKTS:HTHKY) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

  • [By Lisa Levin]

    Thursday morning, the telecommunication services shares rose 1.06 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT), up 5 percent, and Partner Communications Company Ltd. (NASDAQ: PTNR) up 4 percent.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

Top Value Stocks To Watch For 2019: Star Bulk Carriers Corp.(SBLK)

Advisors' Opinion:
  • [By Rich Smith]

    Now those new buy recommendations are rolling in. This morning, Stifel Nicolaus -- one of the best-rated analysts we have on Motley Fool CAPS -- announced a pair of such upgrades, urging investors to buy stock in Scorpio Bulkers (NYSE:SALT) and Star Bulk Carriers (NASDAQ:SBLK). Here's what you need to know.

Thursday, May 24, 2018

Stocks making the biggest moves premarket: BBY, MDT, HRL, MCK, DEO, FOXA, F, GM & more

Check out the companies making headlines before the bell:

Best Buy �� The electronics retailer earned an adjusted 82 cents per share for the first quarter, 8 cents a share above estimates, with revenue also exceeding forecasts. Best Buy reported a comparable store sales increase of 7.1 percent, well above the consensus Thomson Reuters forecast of a 3.0 percent increase.

Medtronic �� The medical device maker's quarterly numbers came in 3 cents above estimates at an adjusted $1.42 per share, with revenue also above Street forecasts. Medtronic benefited from higher demand for its heart-related devices.

Hormel �� The food producer fell a penny a share shy of estimates, with quarterly earnings of 44 cents per share. Revenue was slightly shy of forecasts, as well. Hormel noted higher freight and commodity costs as factors during the quarter, but adds that the quarter did see record profit and that it is maintaining its full-year forecast.

McKesson �� The drug distributor fell 7 cents a share short of estimates, with adjusted quarterly profit of $3.49 per share. Revenue exceeded forecasts, however, and McKesson's board authorized an additional $4 billion stock buyback.

Diageo �� Diageo has begun an auction of its U.S.-focused spirit brands, according to Sky News. Those brands include Myers's Rum and Goldschlager.

21st Century Fox �� Fox is being urged by activist investor Chris Hohn to engage with Comcast, if the NBCUniversal and CNBC parent does make a formal offer for Fox assets that is superior to the deal Fox struck to sell those assets to Walt Disney. Hohn disclosed a 7.4 percent stake in Fox and expressed his view in a letter to Rupert Murdoch that was seen by the Wall Street Journal.

Ford, General Motors �� U.S. auto stocks could get a boost after the Trump administration launched a national security probe into car and truck imports. The probe could lead to new tariffs on imported vehicles.

L Brands �� L Brands reported quarterly profit of 17 cents per share, beating estimates by a penny a share. The Victoria's Secret parent's revenue also beat forecasts, however the company issued weaker-than-expected current-quarter earnings guidance.

Williams-Sonoma �� Williams-Sonoma beat estimates by 9 cents a share, with quarterly profit of 67 cents per share, with revenue above forecasts, as well. The home furnishings retailer also raised its full-year outlook.

Procter & Gamble �� The consumer products company said it would continue investing in Russian plants in the coming years, despite increasing risks due to deteriorating U.S.-Russian relations.

Deutsche Bank �� Deutsche Bank will cut more than 7,000 jobs worldwide, as the bank's new CEO seeks to cut expenses and restore profitability at Germany's largest bank.

Johnson & Johnson �� J&J and its suppliers were hit with a $21.7 million verdict in a case involving a woman who said she developed cancer after being exposed to asbestos in J&J's baby powder product. J&J was assessed 67 percent of the total compensatory damages, with the possible punitive damages still to be determined by the jury.

KKR �� The private-equity firm is in talks to buy privately held BMC Software for about $10 billion, according to the New York Post. Private-equity firms Bain Capital and Golden Gate Capital took BMC private for $6.9 billion in 2013. The paper also said KKR continues to work with hospital operator HCA to bid more than $10 billion for Envision Healthcare.

Kroger �� Kroger is buying Home Chef, the largest privately held provider of meal kits in the U.S. The supermarket chain will pay $200 million up front, and up to $700 million depending on certain performance targets.

NetApp �� NetApp beat estimates by 4 cents a share, with quarterly profit of $1.05 per share. The cloud data company's revenue also topped forecasts.

Darden Restaurants �� Oppenheimer added the parent of Olive Garden, Bahama Breeze, and other restaurant chains to its "Top Picks" list, noting an attractive valuation and the potential for a sizable earnings beat for fiscal 2019.

Tuesday, May 22, 2018

Quants With 20% of U.S. Stock Funds Puzzle Over Timing of Cycle

Wall Street quants are taking sides on the trajectory of the U.S. business cycle -- and money is riding on their investing styles like never before.

The high-stakes call -- risking some of the stock market’s hottest trades -- is reigniting one of the most contested debates in the quantitative community: Can investors time the market? And even if so, should they?

It’s all down to conflicting economic signals in factor investing, which slice and dice equities by their traits like value, volatility and growth. As warnings snowball that markets are entering a new era of tighter global liquidity, the conundrum has gained urgency.

#lazy-img-327919446:before{padding-top:58.91666666666667%;}

In the green corner is Bank of America, which argues U.S. markets are in the throes of mid-cycle expansion. That is, when “macro indicators are generally above average and improving.” If the strategists are right, riskier factors like momentum -- wagering on stocks with the biggest gains over the past year -- will power quants’ money-making engine going forward.

In the red corner are Sanford C. Bernstein analysts. They cite the outperformance of quality factors like low leverage as a signal that developed markets are engulfed in late-cycle angst. If their bearish prognostications come to pass, some of the most popular bets on market leaders like technology shares are headed for danger.

Conflicting signals

For now, there’s data to back up whichever group of quants you believe. Volatile and momentum equities have continued to notch gains, lending credence to the Bank of America mid-cycle thesis. On the other hand, cheap value shares and those with high leverage have slumped -- both characteristics of late-cycle dynamics.

This is far from an esoteric debate for math geeks. A record swath of the global investment community will be affected by structural shifts in factor performance. About 20 percent of managed U.S. stock assets reside in quantitative strategies, and effectively up to 40 percent in passive, according to JPMorgan Chase & Co.

“The center of gravity has been shifting from a primarily active fundamental approach to more of a quantitative/passive approach that should be primarily analyzed through a factor-driven framework,” strategists at the U.S. bank headed by Dubravko Lakos-Bujas wrote in a Friday note. “As a result, the role of factor analysis has gained increasing importance within the investment process.”

Market Clock

Factor timing has also grown popular as quants in a relatively crowded field try to squeeze out alpha, or outperformance, despite skepticism over the strategy. AQR Capital Management, for example, has long argued that it’s unwise to pop in and out of factor investments merely based on valuation.

In a blog post earlier this month, the firm posited that macro factors can’t explain the slump in value stocks across the board. For example, a stock may be cheap either due to weak growth prospects, poor management, or high debt levels. In each scenario, the equity would react differently to say, high inflation, AQR argues.

Others are happy to assign a big-picture rationale. Take the Bernstein analysis. Companies with low levels of leverage have outperformed across the globe this year -- indicating investors are taking a defensive stance to prepare for a downturn in economic momentum.

#lazy-img-327942501:before{padding-top:56.25%;}

A concentrated portfolio that bets on U.S. companies with the most leverage has been falling for six consecutive quarters, the longest losing streak since March 2009, according to a market-neutral Bloomberg index.

“Late expansion and rising rates are good for low leverage stocks,” the Bernstein team, headed by Alla Harmsworth, wrote in a Friday note.

There’s also evidence that investors aren’t confident over the profit outlook. Companies with high earnings growth have outperformed cheaper companies as money managers flock to stocks that have already proven they can supply profits.

Keep the Faith

All that hasn’t deterred Bank of America, however.

“We expect value could lead in the near-term, given a continued acceleration in profits growth (the critical macro driver of style cycles),” Savita Subramanian, head of U.S. equity and quantitative strategy at the bank, wrote in a note last week.

Supporting Subramanian’s call: A momentum strategy -- buying the best performing U.S. shares over the past year and shorting the worst performers -- is on track to post the best first-half performance since 2011. What’s more, equities with the biggest price swings have climbed for the past consecutive seven weeks, the longest streak since 2012. An appetite for riskier, volatile stocks occurs during expansionary periods, according to analysis conducted by JPMorgan and Bank of America, respectively.

#lazy-img-327920297:before{padding-top:56.25%;}

Sure, some of the differences in opinion hinge on how cycles and factors are defined. But with the U.S. economic expansion the second-longest on record, risks for robots and humans alike are rising.

“Momentum becomes most hazardous during contraction when the trends that have driven the market higher until then start to crumble and even reverse,” JPMorgan’s Lakos-Bujas wrote.

LISTEN TO ARTICLE 4:51 Share Share on Facebook Post to Twitter Send as an Email Print

Monday, May 21, 2018

United Continental's CFO Departure: A Warning Sign for Investors

Last week, airline giant United Continental (NYSE:UAL) made a surprising announcement. CFO Andrew Levy has left the company, and will be replaced (on an interim basis, at least) by long-serving United finance executive Gerry Laderman.

This personnel change came as a complete surprise to most industry analysts. While CEO Oscar Munoz was quick to reaffirm the company's existing financial guidance, Levy's departure may indicate brewing problems at United Airlines.

This isn't normal

On the surface, Andrew Levy's departure from United Continental seemed to be on cordial terms. His boss, Munoz, stated that Levy left the company in better financial position than when he arrived. On his LinkedIn page, Levy simply stated, "As satisfying as this job has been, I am considering several exciting opportunities and will choose one in the coming weeks." In a memo to staff, he elaborated that he wanted to return to "more entrepreneurial pursuits."

However, it's unusual (to say the least) for a relatively young executive with one of the most prestigious positions in his field to leave after less than two years with no job lined up.

Indeed, several reports of conflict among United Continental's top executives came to light after Levy's abrupt exit. "My understanding is that Mr. Levy had become frustrated with some things at United that led to a point of no return," said industry analyst Henry Harteveldt (via Forbes). No specifics of his grievances have become public, other than that he may have had major disagreements with United's president, Scott Kirby.

A United Airlines plane flying over a coastline

United's CFO may have left due to infighting among the company's leaders. Image source: United Airlines.

Plenty of questionable moves being made at United

The news of recent executive clashes at United Airlines isn't very surprising. The company has embarked on an ambitious and extremely dangerous strategy in the past year or so. And while United's first-quarter performance and second quarter guidance were better than expected, there will be plenty of potential pitfalls in the months and years ahead.

First, United's profit margin is still on the decline. For the second quarter -- often the most profitable of the year -- the company expects to report an adjusted pre-tax margin between 9% and 11%, down from 13.2% a year earlier. For comparison, United Continental's full-year adjusted pre-tax margin was approximately 12% in both 2015 and 2016.

Second, despite this weakening profitability, United Continental has been taking on more debt to enable share repurchases. Total debt and capital leases surged by nearly $2.7 billion last year, while United's cash balance fell by more than $600 million. This strategy has helped prop up earnings per share (to some extent), but at the cost of making United more vulnerable in the event of an industry downturn.

Third, United Airlines plans to ramp up its capacity growth in the second half of 2018. Much of this additional capacity will operate during off-peak periods. While this strategy will reduce nonfuel unit costs, it will also put pressure on unit revenue, which United can hardly afford after the recent surge in fuel prices.

The exact subject of the disagreements between Levy and Kirby isn't known. However, many of United's recent strategic moves could have elicited sharp criticism internally.

Will management adapt?

In the years after the Great Recession, U.S. airlines routinely responded to rising fuel prices by tapping the brakes on growth. Airline executives reasoned that this was necessary to achieve the level of unit revenue growth that would offset their increased fuel costs. This strategy proved fairly successful over time, allowing airlines to gradually gain credibility with investors.

It will be interesting to see if United Continental's remaining management team proves equally adaptable. Just in the past month, the price of jet fuel has surged by about $0.20 a gallon. This will make it tough for United to stabilize its already-weak pre-tax margin in the second half of 2018 -- particularly if it increases capacity by 5% to 6% or more as planned.

Thus, even if the growth strategy formulated over the past year made sense with oil at $50 or $60 per barrel, it may not be viable with oil near $80 per barrel. If United forges ahead with its growth plan in an�environment of high fuel prices, the results for shareholders could be ugly.

Saturday, May 19, 2018

Columbus Circle Investors Raises Position in Aerie Pharmaceuticals (AERI)

Columbus Circle Investors increased its position in shares of Aerie Pharmaceuticals (NASDAQ:AERI) by 6.4% in the 1st quarter, Holdings Channel reports. The firm owned 631,047 shares of the company’s stock after acquiring an additional 37,961 shares during the period. Columbus Circle Investors’ holdings in Aerie Pharmaceuticals were worth $34,234,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of AERI. QS Investors LLC acquired a new position in shares of Aerie Pharmaceuticals in the fourth quarter worth $125,000. Public Employees Retirement Association of Colorado acquired a new position in shares of Aerie Pharmaceuticals in the fourth quarter worth $176,000. Bamco Inc. NY raised its holdings in shares of Aerie Pharmaceuticals by 19.4% in the fourth quarter. Bamco Inc. NY now owns 7,351 shares of the company’s stock worth $439,000 after acquiring an additional 1,195 shares during the last quarter. California Public Employees Retirement System raised its holdings in shares of Aerie Pharmaceuticals by 47.5% in the third quarter. California Public Employees Retirement System now owns 7,525 shares of the company’s stock worth $366,000 after acquiring an additional 2,425 shares during the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in shares of Aerie Pharmaceuticals in the fourth quarter worth $617,000. 97.57% of the stock is owned by hedge funds and other institutional investors.

Get Aerie Pharmaceuticals alerts:

A number of research firms have recently weighed in on AERI. Cantor Fitzgerald set a $86.00 price target on Aerie Pharmaceuticals and gave the stock a “buy” rating in a report on Tuesday, May 8th. Canaccord Genuity set a $86.00 price target on Aerie Pharmaceuticals and gave the stock a “buy” rating in a report on Tuesday. BidaskClub cut Aerie Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Friday, May 11th. HC Wainwright set a $78.00 price target on Aerie Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, Mizuho cut their price target on Aerie Pharmaceuticals to $77.00 and set a “buy” rating for the company in a report on Tuesday, May 1st. One investment analyst has rated the stock with a sell rating, one has given a hold rating and twelve have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $77.92.

Shares of NASDAQ:AERI opened at $51.15 on Friday. The company has a quick ratio of 13.53, a current ratio of 13.57 and a debt-to-equity ratio of 0.52. Aerie Pharmaceuticals has a 52 week low of $50.38 and a 52 week high of $51.40.

Aerie Pharmaceuticals (NASDAQ:AERI) last announced its quarterly earnings data on Tuesday, May 8th. The company reported ($0.83) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.87) by $0.04. equities analysts anticipate that Aerie Pharmaceuticals will post -3.75 EPS for the current fiscal year.

About Aerie Pharmaceuticals

Aerie Pharmaceuticals, Inc, an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its lead product is Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Want to see what other hedge funds are holding AERI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aerie Pharmaceuticals (NASDAQ:AERI).

Institutional Ownership by Quarter for Aerie Pharmaceuticals (NASDAQ:AERI)